The domestic drug Prolgolimab is included in the list of drugs for the treatment of cancer

News

The decision to use Prolgolimab in urban healthcare was made at the suggestion ofMoscow Cancer Society.

Prolgolimab is a concentrate for the preparation of an infusion solution and is used as part of immunotherapy for the treatment of adult patients who have been diagnosed with melanoma (malignant skin disease).

The high efficacy and good tolerability of the drug is confirmed by real clinical practice.

 

 

#Переведено YandexTranslate
GBUZ Moscow Clinical Scientific Center named after Loginov MHD